Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11494

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

regenerage

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.

recovering patient

The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.

Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”

bioquarklogo

About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About RegenerAge SAPI de CV

RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

China and the US; tensions are mounting and China’s new Quantum Satellite is aiding more fuel to the flames.

By: James Holbrooks (UndergroundReporter) Beijing — Only days after completing production of the largest amphibious aircraft ever built, China has just revealed plans to launch the world’s first satellite designed to conduct quantum experiments in space — a move that could one day lead to a highly secure “orbital internet.”

Assuming the initial satellite performs well, as many as 20 additional craft would follow in the effort to create a new category of communications network. Chinese researchers believe their work could ignite a space race as other nations move to refine the technology.

Read more

An elliptical light beam in a nonlinear optical medium pumped by “twisted light” can rotate like an electron around a magnetic field.

Magnetism and rotation have a lot in common. The effect of a magnetic field on a moving charge, the Lorentz force, is formally equivalent to the fictitious force felt by a moving mass in a rotating reference frame, the Coriolis force. For this reason, atomic quantum gases under rotation can be used as quantum simulators of exotic magnetic phenomena for electrons, such as the fractional quantum Hall effect. But there is no direct equivalent of magnetism for photons, which are massless and chargeless. Now, Niclas Westerberg and co-workers at Heriot-Watt University, UK, have shown how to make synthetic magnetic fields for light [1]. They developed a theory that predicts how a light beam in a nonlinear optical medium pumped by “twisted light” will rotate as it propagates, just as an electron will whirl around in a magnetic field. More than that, the light will expand as it goes, demonstrating fluid-like behavior.

Read more

Lateral photonic integration of oxide-confined leaky vertical-cavity surface-emitting lasers enables their application in data communications and sensing.

Vertical-cavity surface-emitting lasers (VCSELs) that operate at 850nm and are based on oxide-confined apertures are widely used in optical interconnects in data centers, supercomputers, wireless backbone networks, and consumer applications.1 As the processor productivity in these applications increases, it is necessary to continuously improve performance and scale transmission speeds accordingly. In recent years, developers have produced a generation of devices capable of transmitting 40Gb/s at moderate current densities,2, 3 and they have recently demonstrated 54Gb/s non-return-to-zero transmission through 2.2km of multimode fiber.4 Now, 108Gb/s per wavelength transmission can be realized over 100–300m of multimode fiber through the use of advanced modulation formats: discrete multi-tone,5 multiCAP,6 and PAM4.

Read more

Nice!

IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could help enable physicians to detect diseases such as cancer before symptoms appear.

As reported today in the journal Nature Nanotechnology (“Nanoscale Lateral Displacement Arrays for Separation of Exosomes and Colloids Down to 20nm”), the IBM team’s results show size-based separation of bioparticles down to 20 nanometers (nm) in diameter, a scale that gives access to important particles such as DNA, viruses and exosomes. Once separated, these particles can be analyzed by physicians to potentially reveal signs of disease even before patients experience any physical symptoms and when the outcome from treatment is most positive. Until now, the smallest bioparticle that could be separated by size with on-chip technologies was about 50 times or larger, for example, separation of circulating tumor cells from other biological components.

nanoDLD

Continue reading “Lab-on-a-Chip breakthrough aims to help physicians detect cancer and diseases at the nanoscale” | >

Could we see a day when 3D Printers replace convection ovens and microwaves in the kitchen?

Over the last few decades, a new wave of science has been infused into the world of food in the form of molecular gastronomy. By definition, food preparation and cooking involve physical and chemical changes, and molecular gastronomy simply uses scientific principles to take food in new technical and even artistic directions.

It’s also a great excuse to have some fun with liquid nitrogen.

Continue reading “Your Dinner Is Ready To Be 3D Printed” | >

The universe is 13.8 billion years old, while our planet formed just 4.5 billion years ago. Some scientists think this time gap means that life on other planets could be billions of years older than ours. However, new theoretical work suggests that present-day life is actually premature from a cosmic perspective.

“If you ask, ‘When is life most likely to emerge?’ you might naively say, ‘Now,’” says lead author Avi Loeb of the Harvard-Smithsonian Center for Astrophysics. “But we find that the chance of life grows much higher in the distant future.”

Life as we know it first became possible about 30 million years after the Big Bang, when the first stars seeded the cosmos with the necessary elements like carbon and oxygen. Life will end 10 trillion years from now when the last stars fade away and die. Loeb and his colleagues considered the relative likelihood of life between those two boundaries.

Read more

China is planning to build an enormous particle accelerator twice the size and seven times as powerful as CERN’s Large Hadron Collider, according to state media reports. According to China Daily, the new facility will be capable of producing millions of Higgs boson particles — a great deal more than the Large Hadron Collider which originally discovered the ‘God particle’ back in 2012.

Read more